ITC Asks for Comments on Sleep-Disordered Breathing Treatment Devices
The International Trade Commission is asking for comments by April 11 on public interest issues raised by ResMed’s Section 337 patent complaint on sleep-disordered breathing treatment systems and components (see 13040201). According to the underlying petition, the products are used…
Sign up for a free preview to unlock the rest of this article
If your job depends on informed compliance, you need International Trade Today. Delivered every business day and available any time online, only International Trade Today helps you stay current on the increasingly complex international trade regulatory environment.
in the treatment of obstructive sleep apnea by delivering pressurized air to the user to keep that user’s breathing passages open during sleep. ResMed alleges that Apex Medical and Drive Medical Design & Manufacturing manufacture and import breathing treatment systems that infringe its patents. ResMed is requesting cease and desist and limited exclusion orders against the respondents.